Regulatory Complexity Across Southeast Asia
- 2 hours ago
- 3 min read
A medical device company spent 18 months and $2 million preparing to launch in Southeast Asia — despite already holding approvals in the US, EU, Japan, and Australia. They launched three years behind schedule anyway.
The direct answer: every SEA market runs its own approval process, its own timeline, and its own ownership rules — there's no "ASEAN license" that clears all six at once. Singapore approves in 3–6 months; Vietnam can take 18–30. Budget country-specific timelines from day one, not a single regional rollout date.
Why "approved elsewhere" doesn't mean "approved here"
Regulators in Southeast Asia don't recognize each other's approvals, and they rarely recognize approvals from outside the region either. The medical device company above assumed prior clearances would speed things up. Instead, each country demanded its own clinical data. Indonesia required a local manufacturing partner. Vietnam required government tenders before any private sale was allowed. Thailand required Thai-language labelling with font sizes set by law. None of this was hidden — it just wasn't budgeted for. The fix is simple to state and hard to execute: start regulatory prep 24 months before you think you need to.
Regulatory Reality, Country by Country
Singapore — Ease of doing business: #2 globally. Common hurdle: MAS licensing for fintech. Timeline: 3–6 months.
Malaysia — Ease of doing business: #12 globally. Common hurdle: Halal certification for F&B/cosmetics. Timeline: 6–12 months.
Thailand — Ease of doing business: Moderate. Common hurdle: FDA registration for food and health products. Timeline: 9–18 months.
Indonesia — Ease of doing business: Moderate, improving. Common hurdle: BPOM approval for F&B/pharma; local IUMK licensing for retail. Timeline: 12–24 months.
Vietnam — Ease of doing business: Complex. Common hurdle: Ministry-level approvals; foreign ownership caps. Timeline: 18–30 months.
Philippines — Ease of doing business: Challenging. Common hurdle: FDA + DTI registration; 60/40 local ownership rule. Timeline: 12–24 months.
3–6 months fastest market entry (Singapore) | 30 months longest realistic timeline (Vietnam) | 6 markets with entirely separate regulatory regimes
Fast Answers to the Questions Companies Actually Ask
How long does company registration take in Indonesia? Registering the entity itself typically takes weeks. The 12–24 month range comes from BPOM product approval and sector-specific licensing layered on top — budget for the licensing, not just the incorporation.
Does Vietnam allow full foreign ownership? Not universally. Ownership caps apply sector by sector, and several categories require a local joint-venture partner or government tender before commercial sales begin.
Which SEA market is fastest to enter? Singapore, consistently — its rank of #2 globally on ease of doing business reflects a 3–6 month runway for most sectors, MAS-regulated fintech being the main exception.
Do Southeast Asian countries recognize each other's product approvals? No. There is no mutual recognition framework across the six markets above — each requires its own submission, even for products already approved elsewhere in the region.
Success Story: Grab Turned Regulatory Compliance Into a Moat
When GrabPay pursued e-money licences across the region, most observers expected a multi-year, multi-million-dollar slog. Grab treated the process as a strategic investment instead: it hired former central bank executives, built dedicated government relations teams in each market, and shared data proactively with regulators to build trust. By 2023, GrabPay held payment licences in Singapore, Malaysia, Thailand, the Philippines, Indonesia, and Vietnam. The payoff wasn't just compliance — those relationships became a moat, making it far harder for fast-moving competitors to replicate Grab's cross-border payment infrastructure.
Cautionary Tale: The Medical Device Company That Assumed Approval Would Transfer
Same story as the opening: US, EU, Japan, and Australia approvals in hand, a company assumed Southeast Asia would follow the same path. It didn't. Separate clinical submissions per country, a mandatory local manufacturing partner in Indonesia, government tenders in Vietnam, and Thai-language labelling requirements in Thailand added up to 18 months and $2 million in prep — and a launch three years later than planned.
About Us
Curt & Co Pte Ltd is a consulting company started amongst a group of business owners who were looking for a consulting company themselves for advice !
Our offices and our focus markets are in Philippines, Indonesia, Singapore, Vietnam and Malaysia. With clients ranging from 1 man operating SMEs to listed companies, we are proud to have helped our clients across different industries gain market entry into the South East Asian region.
Contact us at marcus@curtconsult.com if you want to talk!
Comments